MediPines
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22755 Savi Ranch Pkwy Ste C, Yorba Linda...Website
www.medipines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About MediPines
MediPines specializes in non-invasive cardiorespiratory assessment technology, particularly through their flagship product, the AGM100. This innovative device provides rapid and accurate detection of respiratory impairment, enabling clinicians to make informed decisions in emergency care settings. The AGM100 is designed for use by qualified medical staff, offering actionable results in under two minutes, thereby improving patient safety and streamlining healthcare workflows. Targeted primarily at healthcare providers, MediPines aims to enhance the diagnosis and management of respiratory conditions such as COPD, pneumonia, and acute asthma.Explore more
MediPines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MediPines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if MediPines has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on MediPines recently announced quarterly report
Funding: Get notified immidiatlly once MediPines has new funding data
Product Launch: Get notified when MediPines launches new products
Check out if MediPines is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if MediPines had a recent Job posting/layoffs
MediPines, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at MediPines
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at MediPines
Find more new buyers
Compare Similar Companies to MediPines
Compare insights from companies similar to MediPines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MediPines is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MediPines is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MediPines.
MediPines financials insights
Gather financial insights about MediPines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Private Equity
$563K
2015
Private Equity
$2M
MediPines Tech Stack
A closer look at the technologies used by MediPines
See more technologies
MediPines News & Media
UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza
SAN DIEGO--(BUSINESS WIRE)-- #GreggLSemenza--MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, and maker of AGM100, will sponsor this year’s annual UCSD John B. West Distinguished Lecture event featuring Nobel Laureate Gregg L. Semenza, MD, PhD. The lecture, titled “Hypoxia-Inducible Factors in Physiology and Medicine,” will take place on August 7, 2023 at noon Pacific Time via livestream from UCSD. “We’re honored to be hosting the esteemed Dr. Semenza, aMediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Southeast Asia
YORBA LINDA, Calif.--(BUSINESS WIRE)-- #innovation--MediPines, the pioneering market leader in non-invasive pulmonary gas exchange technology, today announced that its MediPines AGM100 non-invasive pulmonary gas exchange analyzer technology is now available in Southeast Asia through a sales and marketing agreement with Ambica International, one of the region’s leading providers of pharmaceuticals and medical devices. The MediPines AGM100 is an FDA-cleared, advanced pulmonary gas exchange technolMediPines Expands Distribution of its Pulmonary Gas Exchange Tech
MediPines announced that its FDA-cleared, non-invasive pulmonary gas exchange analyzer, the MediPines AGM100, is now available in Canada.MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada
YORBA LINDA, Calif.--(BUSINESS WIRE)-- #AGM100--Orange County, California based MediPines, a global market leader in the development of gas exchange measurements, has announced that its MediPines AGM100, the world’s first FDA-cleared, non-invasive pulmonary gas exchange analyzer, is now available throughout Canada, thanks to an agreement with LevoMed Canada Inc., a company focused on providing the Canadian health care market with high quality innovative products. This Canadian national distribut
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MediPines
Sign Up For FreeTo access detailed company insights
MediPines specializes in non-invasive cardiorespiratory assessment technology, particularly through their flagship product, the AGM100. This innovative device provides rapid and accurate detection of respiratory impairment, enabling clinicians to make informed decisions in emergency care settings. The AGM100 is designed for use by qualified medical... Read More
